Cardiol Therapeutics Inc.
CRDL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $126,191 | $152,891 | $115,253 | $128,561 |
| - Cash | $11,622 | $18,195 | $23,293 | $30,580 |
| + Debt | $134 | $143 | $151 | $159 |
| Enterprise Value | $114,703 | $134,839 | $92,111 | $98,139 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$34 |
| % Margin | – | – | – | – |
| EBITDA | -$9,939 | -$7,651 | -$8,404 | -$5,649 |
| % Margin | – | – | – | – |
| Net Income | -$9,964 | -$8,354 | -$8,288 | -$5,683 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.1 | -0.1 | -0.12 |
| % Growth | -20% | 0% | 16.7% | – |
| Operating Cash Flow | -$6,925 | -$4,551 | -$7,154 | -$5,593 |
| Capital Expenditures | -$3 | -$6 | -$12 | -$6 |
| Free Cash Flow | -$6,928 | -$4,557 | -$7,166 | -$5,599 |